Most Favored Nation would tie US drug prices to which countries?
A press release from CMS today provides the answer: [The Department of Health and Human Services] HHS expects each manufacturer to commit to aligning US pricing for all brand products across all markets that do not currently have generic or biosimilar competition with the lowest price of a set of economic peer countries. The MFN…